L3VLUP
ProSign in

HAE in the 13F filings

Haemonetics Corp Mass · CUSIP 405024100

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Dec 2023
the date the book describes
Filed
14 Nov 2024
latest of these filings; the earliest 9 Feb 2024
Managers listing it
6
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q3 2023 and Q4 2023; 6 listed it in both
Shares listed
13,665,943
combined, among listed positions
Reported value
$1.2bn
combined, at the quarter end

Among the 93 comparable managers: 1 buyer (opened or added shares) and 6 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -238,696.

Managers listing HAE in Q4 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

6 of 6 holders

ActionFiling
Capital Research Global Investors6,523,568$558m0.14%Trimmed-99,58013 Feb 2024 (the filing on sec.gov)
Neuberger Berman Group LLC3,531,181$302m0.26%Trimmed-36,60014 Nov 2024 (the filing on sec.gov)
Wellington Management Group LLP3,268,083$279m0.05%Added+101,02912 Feb 2024 (the filing on sec.gov)
Arrowstreet Capital LP158,017$14munder 0.1%Trimmed-77,18714 Feb 2024 (the filing on sec.gov)
Two Sigma Advisers LP130,355$11munder 0.1%Trimmed-90,40014 Feb 2024 (the filing on sec.gov)
Bridgewater Associates LP54,739$4.7munder 0.1%Trimmed-5,41314 Feb 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2023 to Q4 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
5 in Q3 2024 to 6 in Q2 2026

Tracked managers listing it, at least.

051015202014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
HAE by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20133$256mn.a.n.a.
Q3 20133$295mn.a.n.a.
Q4 20133$328mn.a.n.a.
Q1 20144$186mn.a.n.a.
Q2 20141$195mn.a.n.a.
Q3 20141$180mn.a.n.a.
Q4 20141$183mn.a.n.a.
Q1 20151$203mn.a.n.a.
Q2 20151$172mn.a.n.a.
Q3 20151$120mn.a.n.a.
Q4 20151$77mn.a.n.a.
Q1 20162$244mn.a.n.a.
Q2 20162$211mn.a.n.a.
Q3 20165$447mn.a.n.a.
Q4 20166$470mn.a.n.a.
Q1 20174$258mn.a.n.a.
Q2 20177$264mn.a.n.a.
Q3 20176$316mn.a.n.a.
Q4 201714$524mn.a.n.a.
Q1 20188$694mn.a.n.a.
Q2 201815$896mn.a.n.a.
Q3 201812$1.5bnn.a.n.a.
Q4 201811$1.3bnn.a.n.a.
Q1 201913$1.2bnn.a.n.a.
Q2 201914$1.8bnn.a.n.a.
Q3 201911$1.8bnn.a.n.a.
Q4 201914$1.6bnn.a.n.a.
Q1 202014$1.1bnn.a.n.a.
Q2 202014$1.2bnn.a.n.a.
Q3 202016$1.3bnn.a.n.a.
Q4 202011$1.6bnn.a.n.a.
Q1 202111$1.5bnn.a.n.a.
Q2 20218$741mn.a.n.a.
Q3 202111$843mn.a.n.a.
Q4 202110$649mn.a.n.a.
Q1 20229$1.0bnn.a.n.a.
Q2 20228$1.1bnn.a.n.a.
Q3 20228$1.3bnn.a.n.a.
Q4 20228$1.2bnn.a.n.a.
Q1 20237$1.2bnn.a.n.a.
Q2 20237$1.2bnn.a.n.a.
Q3 20237$1.2bnn.a.n.a.
Q4 20236$1.2bn16
Q1 20246$1.3bn51
Q2 20245$1.2bn33
Q3 20245$1.0bn41
Q4 20245$986m32
Q1 20259$622m54
Q2 20259$666m45
Q3 20255$323m42
Q4 20258$894m1714
Q1 20263$464m1617
Q2 20266$619m1218

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

HAE and LLY →HAE and JNJ →HAE and VRTX →Choose a stock to compare with HAE →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own HAE, latest filings →Back to the 13F Explorer →